News

We will hold the Zoom webinar on the latest update of antibody-related technology on Jan 22, 2026.

This webinar will be conducted in English and we welcome participation from all over the world!

Click here to register

-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-
Functions of cancer-associated glycolipids and challenges to generate antibodies

Speaker:
Koichi Furukawa, M.D., Ph.D.
Professor Emeritus, Nagoya University Graduate School of Medicine
Fellow, Chubu University College of Life and Health Sciences, Department of Biomedical Sciences

Lecture Abstract:
Cancer cells frequently express unique antigens that are not found in normal cells. Various cancer-associated antigens have been elucidated to be glycosphingolipids, and have been used for diagnosis and therapeutics. Furthermore, their roles in the cancer development and expansion have been clarified using novel approaches. In particular, antibodies reactive with those cancer-associated glycolipids have played important roles in those functional analyses and also investigation of the molecular mechanisms for the carbohydrate structures on the cancer-associated antigens. In this presentation, recent findings on the functions of those glycolipids and our challenges to generate efficient antibodies, in particular using glycolipid-lacking knockout mice, will be reported.

-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-

Date & Time:
Jan. 22th 3-4pm PST / 6-7pm EST

Before Dr. Furukawa’s lecture, iBody will give a 10-minute
introduction on its proprietary antibody discovery technology.

Participation Fee: Free of charge
Venue: Online via Zoom

Organizer:
iBody Inc.
Email: info-wb@ibody.co.jp
LinkedIn：https://www.linkedin.com/company/ibody2018